Insider · CIK 0001851640
Robin Wright
Files at BRNS (Barinthus Biotherapeutics plc.). First filing -, latest -.
Robin Wright files SEC Form 4 as director at BRNS (Barinthus Biotherapeutics plc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Robin Wright has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | BRNS Barinthus Biotherapeutics plc. | DDisposition to issuer Ordinary Shares | -48,256 | - | - | 0 | 34 d ago |
| Sep 9, 2026 | BRNS Barinthus Biotherapeutics plc. | DDisposition to issuer Share Option (Right to Buy)derivative | -20,394 | $0.00 | $0 | 0 | 34 d ago |
| Sep 9, 2026 | BRNS Barinthus Biotherapeutics plc. | DDisposition to issuer Share Option (Right to Buy)derivative | -34,328 | $0.00 | $0 | 0 | 34 d ago |
| Sep 9, 2026 | BRNS Barinthus Biotherapeutics plc. | DDisposition to issuer Share Option (Right to Buy)derivative | -18,604 | $0.00 | $0 | 0 | 34 d ago |
| Sep 9, 2026 | BRNS Barinthus Biotherapeutics plc. | DDisposition to issuer Share Option (Right to Buy)derivative | -19,197 | $0.00 | $0 | 0 | 34 d ago |
| Sep 9, 2026 | BRNS Barinthus Biotherapeutics plc. | DDisposition to issuer Share Option (Right to Buy)derivative | -19,516 | $0.00 | $0 | 0 | 34 d ago |
| Sep 9, 2026 | BRNS Barinthus Biotherapeutics plc. | DDisposition to issuer Share Option (Right to Buy)derivative | -20,174 | $0.00 | $0 | 0 | 34 d ago |
| Jun 10, 2025 | BRNS Barinthus Biotherapeutics plc. | AGrant or award Share Option (Right to Buy)derivative | +20,174 | $0.00 | $0 | 20,174 | Jun 11, 2025 |
Questions about Robin Wright
Answered from the filings on this page, as of the latest one.
Is Robin Wright buying or selling?
Robin Wright has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Robin Wright's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Robin Wright has 0.
Where does Robin Wright file Form 4?
Robin Wright has filed Form 4 at BRNS (Barinthus Biotherapeutics plc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.